Stocks
MetLife Financial Statements (MET) |
||||||||||
| MetLifesmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 19.02.2021 | 18.02.2022 | 31.12.2022 | 23.02.2023 | 16.02.2024 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 67 842 | 71 080 | 69 898 | 69 898 | 66 407 | 67 574 | |||
| Operating Income, bln rub | 5 067 | 5 486 | 0.000 | 3 105 | 1 643 | 1 570 | ||||
| EBITDA, bln rub | ? | 5 686 | 6 180 | 3 778 | 3 778 | 2 361 | 1 570 | |||
| Net profit, bln rub | ? | 5 407 | 6 855 | 2 539 | 2 354 | 1 578 | 2 365 | |||
| OCF, bln rub | ? | 11 639 | 12 596 | 4 428 | 13 204 | 13 721 | 14 023 | |||
| CAPEX, bln rub | ? | 4 269 | 4 360 | 0.000 | 0.000 | 1 170 | 1 580 | |||
| FCF, bln rub | ? | 7 370 | 16 956 | 4 428 | 13 204 | 12 551 | 14 837 | |||
| Dividend payout, bln rub | 1 859 | 1 842 | 5 168 | 1 783 | 1 764 | 1 309 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 34.4% | 26.9% | 203.5% | 75.7% | 111.8% | 55.3% | ||||
| OPEX, bln rub | 62 775 | 65 594 | 0.000 | 67 039 | 64 764 | 66 004 | ||||
| Cost of production, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 913.0 | 920.0 | 938.0 | 938.0 | 1 045 | 1 054 | ||||
| Assets, bln rub | 795 146 | 759 708 | 666 611 | 666 611 | 687 584 | 677 576 | ||||
| Net Assets, bln rub | ? | 74 558 | 67 482 | 27 040 | 27 040 | 30 015 | 28 535 | |||
| Debt, bln rub | 18 149 | 17 430 | 17 980 | 17 980 | 18 828 | 16 099 | ||||
| Cash, bln rub | 378 508 | 367 497 | 301 910 | 301 910 | 308 096 | 298 249 | ||||
| Net debt, bln rub | -360 359 | -350 067 | -283 930 | -283 930 | -289 268 | -282 150 | ||||
| Ordinary share price, rub | 47.0 | 62.5 | 72.4 | 72.4 | 66.1 | 60.0 | ||||
| Number of ordinary shares, mln | 907.8 | 862.7 | 779.1 | 803.2 | 757.7 | 0.000 | ||||
| Market cap, bln rub | 42 621 | 53 910 | 56 383 | 58 128 | 50 107 | 0 | ||||
| EV, bln rub | ? | -317 738 | -296 157 | -227 547 | -225 802 | -239 161 | -282 150 | |||
| Book value, bln rub | 45 758 | 39 614 | 17 743 | -7 716 | -166 | 19 498 | ||||
| EPS, rub | ? | 5.96 | 7.95 | 3.26 | 2.93 | 2.08 | ||||
| FCF/share, rub | 8.12 | 19.7 | 5.68 | 16.4 | 16.6 | |||||
| BV/share, rub | 50.4 | 45.9 | 22.8 | -9.61 | -0.22 | |||||
| EBITDA margin, % | ? | 8.38% | 8.69% | 5.41% | 5.41% | 3.56% | 2.32% | |||
| Net margin, % | ? | 7.97% | 9.64% | 3.63% | 3.37% | 2.38% | 3.50% | |||
| FCF yield, % | ? | 17.3% | 31.5% | 7.85% | 22.7% | 25.0% | 0.00% | |||
| ROE, % | ? | 7.25% | 10.2% | 9.39% | 8.71% | 5.26% | 8.29% | |||
| ROA, % | ? | 0.68% | 0.90% | 0.38% | 0.35% | 0.23% | 0.35% | |||
| P/E | ? | 7.88 | 7.86 | 22.2 | 24.7 | 31.8 | 0.00 | |||
| P/FCF | 5.78 | 3.18 | 12.7 | 4.40 | 3.99 | 0.00 | ||||
| P/S | ? | 0.63 | 0.76 | 0.81 | 0.83 | 0.75 | 0.00 | |||
| P/BV | ? | 0.93 | 1.36 | 3.18 | -7.53 | -301.8 | 0.00 | |||
| EV/EBITDA | ? | -55.9 | -47.9 | -60.2 | -59.8 | -101.3 | -179.7 | |||
| Debt/EBITDA | -63.4 | -56.6 | -75.2 | -75.2 | -122.5 | -179.7 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
| CAPEX/Revenue, % | 6.29% | 6.13% | 0.00% | 0.00% | 1.76% | 2.34% | ||||
| MetLife shareholders | ||||||||||
